Kevin Markey - Concepedia

Author

Kevin Markey

National Institute for Biological Standards and Control ORCID

Also Known As

K Markey, K. Markey, Kevin M. Markey, Kevin Markey

Publications

418

Citations

H-Index

Concepts

All Affiliations

National Institute for Biological Standards and Control Capital Medical University University of Turku Turku University Hospital Statens Serum Institut

About

Kevin Markey is an author at National Institute for Biological Standards and Control specializing in medicine, immunology, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	142
2	Allergy	1	1	14
3	Cell Biology	1	1	32
4	Emergency Medicine	1	1	21
5	Epidemiology	1	1	21

Kevin Markey

Publications

317

Citations

H-Index

Page 1

	Year	Citations
Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015 Alex‐Mikael Barkoff, Jussi Mertsola, Denis Piérard, Eurosurveillance	2019	96
Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015 Alex‐Mikael Barkoff, Jussi Mertsola, Denis Piérard, Journal of Clinical Microbiology	2018	41
Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells Thomas J. Mullen, Kevin Markey, Philip G. Murphy, European Journal of Clinical Microbiology & Infectious Diseases Lung Epithelial CellsInflammatory Lung DiseasePathogenesisPathologyBurkholderia Cepacia Complex	2007	32
Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains Mei Mei Ho, Kevin Markey, Peter Rigsby, Vaccine VaccinationInternational Collaborative StudyVaccine DevelopmentDifferent Sub-strainsImmunology	2010	25
EUVAC.NET collaborative study: Evaluation and standardisation of serology for diagnosis of pertussis Dorothy Xing, Kevin Markey, Penny Newland, Journal of Immunological Methods MedicineDiagnostic TestPatient SafetyDiagnosisEuvac.net Collaborative Study	2011	21
Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine Kevin Markey, Mei Mei Ho, Babna Choudhury, Vaccine VaccinationInternational Collaborative StudyVaccine DevelopmentVaccine TargetMultiplex Pcr	2010	20
Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine Mei Mei Ho, Kevin Markey, Peter Rigsby, Vaccine VaccinologyVaccinationVaccine SafetyViable CountInternational Collaborative Study	2008	18
Improvement in serological diagnosis of pertussis by external quality assessment Kevin Markey, Alex Douglas-Bardsley, Cathy Asokanathan, Journal of Medical Microbiology	2019	15
Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay. Kevin Markey, A. Douglas-Bardsley, Jason Hockley, PubMed World Health OrganizationImmunodeficienciesImmunologyPertussis ToxinVaccine Surveillance	2018	14
Differences in epitope‐specific antibodies to pertussis toxin after infection and acellular vaccinations Aapo Knuutila, Tine Dalby, Alex‐Mikael Barkoff, Clinical & Translational Immunology	2020	13

Page 1